Rutgers researchers have discovered what could be the newest target for drugs in the treatment of memory and learning disabilities as well as diseases such as Alzheimer’s and fetal alcohol syndrome: a protein known as cypin.
Rutgers researchers have discovered what could be the newest target for drugs in the treatment of memory and learning disabilities as well as diseases such as Alzheimer’s and fetal alcohol syndrome: a protein known as cypin.
